Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Milton K. Erman"'
Publikováno v:
Sleep Medicine. 38:92-95
In evaluating pathologic sleepiness, the Epworth Sleepiness Scale (ESS) assesses subjective sleep propensity; the Maintenance of Wakefulness Test (MWT) is an objective measure of the ability to stay awake. This analysis evaluated the strength of the
Autor:
Emil Chuang, Howard Schwartz, Warren A. Prosser, Milton K. Erman, Matilde Sanchez, Thomas Roth, Christen M. Anderson, Steven Hull, Russell Rosenberg, William R. Shanahan, David Seiden
Publikováno v:
Sleep. 31:1663-1671
THE PREVALENCE OF INSOMNIA COMPLAINTS IN DEVELOPED COUNTRIES IS ESTIMATED TO BE 25% TO 35% IN SEVERAL GENERAL POPULATION SURVEYS1–3 and includes 30 to 45 million Americans who have a diagnosis of insomnia.4 The DSM-IV defines insomnia as difficulty
Autor:
Jonathan R.L. Schwartz, Jeffrey M. Dayno, Max Hirshkowitz, Sanjay Arora, Milton K. Erman, Thomas Roth
Publikováno v:
Journal of Clinical Sleep Medicine. :595-602
Study Objectives:Modafinil is a wake-promoting agent shown to improve wakefulness in patients with excessive sleepiness (hypersomnolence) associated with shift work sleep disorder, obstructive slee...
Autor:
Eileen Casal, Athena Philis-Tsimikas, Daniel Einhorn, Milton K. Erman, Nancy Gordon, Deirdre A. Stewart
Publikováno v:
Endocrine Practice. 13:355-362
To assess the prevalence of sleep apnea (SA) in adults with type 2 diabetes mellitus (T2DM) and examine whether demographics and comorbid factors were associated with SA in this population.This study enrolled 330 consecutive adults with T2DM referred
Publikováno v:
Journal of Clinical Sleep Medicine. :387-392
Sleep apnea is a common disorder that affects more than 20 million adult Americans.1 It is associated with poor sleep quality, excessive daytime sleepiness,2 and decreased quality of life.3 Sleep apnea has been shown to have an increased prevalence i
Autor:
Milton K. Erman, Russell Rosenberg
Publikováno v:
The Primary Care Companion to The Journal of Clinical Psychiatry. :188-194
Objective: We evaluated the effects of modafinil, a wake-promoting agent, on patient functioning, health-related quality of life, and nighttime and daytime sleep in patients with excessive sleepiness associated with shift work sleep disorder (SWSD).
Publikováno v:
Sleep Medicine. 7:17-24
Background and purpose To evaluate the efficacy, safety, and dose response of Ramelteon, a novel highly selective MT 1 /MT 2 receptor agonist, in patients with chronic primary insomnia. Patients and methods A randomized, multicenter, double-blind, pl
Publikováno v:
Current Medical Research and Opinion. 21:223-229
Objective To compare the effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance during the last third of the night (last 160 min) and on sleep architecture throughout the night. Research design and methods This was a retrospective analy
Publikováno v:
Chest. 124:2192-2199
Study objectives The purpose of this 12-week study was to evaluate the efficacy and safety of adjunct modafinil to treat excessive sleepiness in patients with obstructive sleep apnea (OSA) who experience residual sleepiness despite regular nasal cont
Autor:
C. W. Erwin, Andrew O. Jamieson, Helio Lemmi, J. Catesby Ware, Quentin R. Regestein, Francis M. Gengo, Thomas Roth, Milton K. Erman, Barbara Roth-Schechter, James K. Walsh, Mark W. Mahowald, Martin B. Scharf, Gerald W. Vogel
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 16:169-176
This study compared hypnotic effects of zolpidem 10 mg, temazepam 15 mg and placebo in healthy adults. Two factors expected to promote insomnia, the 'first night effect' and a 2-hour phase advance, were combined in a single night laboratory-based dou